Table 2

Visit schedule during the clinical trial

Visit 1, day 0Visit 2*, day 2–3Visit 3, day 14–28†Visit 4*, day 90
Medical history and physical examinationxx
Informed consent formx
Giving out of symptom diariesx
Evaluation of clinical evolutionxx
Assessment of adverse eventsxx
Collection of symptom diariesx
Reporting of recurrences, medical visits or hospital admissions due to the baseline infectionxxx
  • *Phone call.

  • †Depending on the infection (14 days for influenza and sore throat; 28 days for acute bronchitis and acute rhinosinusitis). A further visit should be scheduled if symptoms persist on visit 3.